Search research articles
Contact Us
Filters
Showing results (11-20 of 168) with videos related to
Page
of 17
Sort By:
Gynecologic Oncology
|
September 7, 2007
Chemotherapy for recurrent cervical cancer
Isabelle Cadron, Toon Van Gorp, Frederic Amant, et al.
Gynecologic Oncology
|
May 15, 2007
The "Leuven" dose-dense paclitaxel/carboplatin regimen in patients with recurrent ovarian cancer
Isabelle Cadron, Karin Leunen, Frédéric Amant, et al.
Current Opinion in Oncology
|
August 9, 2006
The management of borderline tumours of the ovary
Isabelle Cadron, Frederic Amant, Toon Van Gorp, et al.
American Journal of Obstetrics and Gynecology
|
March 10, 2007
Laparoscopy-assisted vaginal hysterectomy compared with abdominal hysterectomy in clinical stage I endometrial cancer: safety, recurrence, and long-term outcome
Ioannis Kalogiannidis, Sandrijne Lambrechts, Frederic Amant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2007
Management of borderline ovarian neoplasms
Isabelle Cadron, Karin Leunen, Toon Van Gorp, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
August 6, 2010
The role of diaphragmatic surgery during interval debulking after neoadjuvant chemotherapy: an analysis of 74 patients with advanced epithelial ovarian cancer
Dimitris Tsolakidis, Frederic Amant, Toon Van Gorp, et al.
Gynecologic Oncology
|
October 9, 2009
Application of proteomics in ovarian cancer: which sample should be used?
Isabelle Cadron, Toon Van Gorp, Dirk Timmerman, et al.
Journal of Ovarian Research
|
November 10, 2019
Organoids of epithelial ovarian cancer as an emerging preclinical in vitro tool: a review
Sander Dumont, Ziga Jan, Ruben Heremans, et al.
Expert Opinion on Investigational Drugs
|
February 21, 2023
Investigational drugs for recurrent or primary advanced metastatic cervical cancer: what is in the clinical development pipeline?
Ignace Vergote, Isabelle Ray-Coquard, Domenica Lorusso, et al.
Proteome Science
|
June 15, 2012
Proteomic biomarkers predicting lymph node involvement in serum of cervical cancer patients. Limitations of SELDI-TOF MS
Toon Van Gorp, Isabelle Cadron, Anneleen Daemen, et al.
Page
of 17
Search research articles
Search
Showing results (11-20 of 168) with videos related to
Sort By:
Page
of 17
Gynecologic Oncology
|
September 7, 2007
Chemotherapy for recurrent cervical cancer
Isabelle Cadron, Toon Van Gorp, Frederic Amant, et al.
Gynecologic Oncology
|
May 15, 2007
The "Leuven" dose-dense paclitaxel/carboplatin regimen in patients with recurrent ovarian cancer
Isabelle Cadron, Karin Leunen, Frédéric Amant, et al.
Current Opinion in Oncology
|
August 9, 2006
The management of borderline tumours of the ovary
Isabelle Cadron, Frederic Amant, Toon Van Gorp, et al.
American Journal of Obstetrics and Gynecology
|
March 10, 2007
Laparoscopy-assisted vaginal hysterectomy compared with abdominal hysterectomy in clinical stage I endometrial cancer: safety, recurrence, and long-term outcome
Ioannis Kalogiannidis, Sandrijne Lambrechts, Frederic Amant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2007
Management of borderline ovarian neoplasms
Isabelle Cadron, Karin Leunen, Toon Van Gorp, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
August 6, 2010
The role of diaphragmatic surgery during interval debulking after neoadjuvant chemotherapy: an analysis of 74 patients with advanced epithelial ovarian cancer
Dimitris Tsolakidis, Frederic Amant, Toon Van Gorp, et al.
Gynecologic Oncology
|
October 9, 2009
Application of proteomics in ovarian cancer: which sample should be used?
Isabelle Cadron, Toon Van Gorp, Dirk Timmerman, et al.
Journal of Ovarian Research
|
November 10, 2019
Organoids of epithelial ovarian cancer as an emerging preclinical in vitro tool: a review
Sander Dumont, Ziga Jan, Ruben Heremans, et al.
Expert Opinion on Investigational Drugs
|
February 21, 2023
Investigational drugs for recurrent or primary advanced metastatic cervical cancer: what is in the clinical development pipeline?
Ignace Vergote, Isabelle Ray-Coquard, Domenica Lorusso, et al.
Proteome Science
|
June 15, 2012
Proteomic biomarkers predicting lymph node involvement in serum of cervical cancer patients. Limitations of SELDI-TOF MS
Toon Van Gorp, Isabelle Cadron, Anneleen Daemen, et al.
Page
of 17